Newsfeeds - Spark Newswire

2 minute read

Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken

Today, 3:59 PM

Some Asian firms have disclosed cash deposits at troubled U.S. lender Silicon Valley Bank (NASDAQ: SIVB), known for its deep ties with the healthcare and tech sector. Most emphasized that the amounts were immaterial to their operations.

BGNE

1 minute read

Cowen & Co. Maintains Outperform on BeiGene, Raises Price Target to $262

By Benzinga Newsdesk

Today, 3:59 PM

Cowen & Co. analyst Yaron Weber maintains BeiGene (NASDAQ:BGNE) with a Outperform and raises the price target from $213 to $262.

BGNE

1 minute read

Morgan Stanley Maintains Overweight on BeiGene, Lowers Price Target to $321

By Benzinga Newsdesk

Today, 3:59 PM

Morgan Stanley analyst Matthew Harrison maintains BeiGene (NASDAQ:BGNE) with a Overweight and lowers the price target from $325 to $321.

BGNE

3 minute read

Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk

By Shanthi Rexaline

Today, 3:59 PM

US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could trigger bargain-hunting-related buying.

BGNE

1 minute read

Morgan Stanley Maintains Overweight on BeiGene, Raises Price Target to $325

By Benzinga Newsdesk

Today, 3:59 PM

Morgan Stanley analyst Matthew Harrison maintains BeiGene (NASDAQ:BGNE) with a Overweight and raises the price target from $295 to $325.

BGNE

1 minute read

Analyst Ratings

4 Analysts Have This to Say About BeiGene

By Benzinga Insights

Today, 3:59 PM

Within the last quarter, BeiGene (NASDAQ:BGNE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

BGNE

1 minute read

FDA Approves BeiGene’s Brukinsa For Chronic Lymphocytic Leukemia

By Vandana Singh

Today, 3:59 PM

The FDA has approved BeiGene Ltd’s (NASDAQ:BGNE) Bruton’s tyrosine kinase inhibitor (BTKi) Brukinsa (zanubrutinib) for chronic lymphocytic leukemia (CLL) or small lymphocytic…

BGNE

1 minute read